At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Indocyanine Greenother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Quantitative Fluorescent Guided Robotic Surgery for Cancer of the Gastroesophageal Junction
In Brief
A clinical study evaluating Indocyanine Green for Stomach Neoplasms and Surgery. Completed, enrolled 70 participants across 1 site.
Detailed Summary
The investigators also aim to use our previously described quantifying method (q-ICG), to evaluate changes in gastric perfusion, during resection of cancer in the gastroesophageal junction (GEJ) and if a change in the operative technique influences microvascular flow in the gastroesophageal (GE) anastomosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStomach Neoplasms, Surgery
CountriesDenmark
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedSep 2019
Enrollment StartJun 2020
Primary CompletionOct 2021
TodayJul 2026
First PostedSep 27, 2019
Enrollment StartJun 16, 2020
Primary CompletionOct 13, 2021
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 6.8 years ago
Interventions
Indocyanine Greenother
Using Q-ICG perfusion of the remaining Gastric Conduit will be compared